
### [NCIT:C7690](http://purl.obolibrary.org/obo/NCIT_C7690)
**Label:** Intraductal and Lobular Carcinoma

**Subclasses:** [NCIT:C4195](http://purl.obolibrary.org/obo/NCIT_C4195) (Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ), [NCIT:C6939](http://purl.obolibrary.org/obo/NCIT_C6939) (Ductal Breast Carcinoma In Situ and Invasive Lobular Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 54.24%
- [NCIT:C36879](http://purl.obolibrary.org/obo/NCIT_C36879) (Lobular Carcinoma Cell) 51.79%
- [NCIT:C36878](http://purl.obolibrary.org/obo/NCIT_C36878) (Neoplastic Lobular Epithelial Cell) 51.79%
- [NCIT:C36877](http://purl.obolibrary.org/obo/NCIT_C36877) (Neoplastic Ductal Epithelial Cell) 51.79%
- [NCIT:C36858](http://purl.obolibrary.org/obo/NCIT_C36858) (Ductal Carcinoma Cell) 51.79%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.14%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 37.14%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 37.14%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 37.14%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 37.14%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 37.14%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 37.14%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 37.14%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 37.14%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 37.14%


